USFDA gives Orphan Drug Designation and Rare Paediatric Disease ... - BioSpectrum Asia

HKBU and Shanghai Sixth People's Hospital discovered an aptamer, Apc001, effective for X-linked hypophosphatemia (XLH). Granted Orphan Drug and Pediatric Rare Disease Designations by the FDA, Apc001 is set for clinical trials in Mainland China and the US.


Related News

USFDA gives Orphan Drug Designation and Rare Paediatric Disease ... - BioSpectrum Asia

HKBU and Shanghai Sixth People's Hospital discovered an aptamer, Apc001, effective for X-linked hypophosphatemia (XLH). Granted Orphan Drug and Pediatric Rare Disease Designations by the FDA, Apc001 is set for clinical trials in Mainland China and the US.

© Copyright 2024. All Rights Reserved by MedPath